Tiedemann Advisors, LLC Novo Nordisk A S Transaction History

Tiedemann Advisors, LLC

$2.31 Billion
Q3 2023

A detailed history of Tiedemann Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 4,314 shares of NVO stock, worth $382,694. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,314

Previous 2,202 95.91%

Holding current value

$382,694

Previous $356,000 10.11%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $192,065 - $421,428	2,112 Added 95.91%	4,314 $392,000
Q2 2023 Jul 20, 2023	BUY	$155.98 - $172.65 $7,019 - $7,769	45 Added 2.09%	2,202 $356,000
Q1 2023 Apr 26, 2023	SELL	$132.34 - $159.14 $397 - $477	-3 Reduced 0.14%	2,157 $343,000
Q2 2022 Aug 03, 2022	SELL	$103.24 - $121.81 $293,098 - $345,818	-2,839 Reduced 56.79%	2,160 $241,000
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $93 - $112	-1 Reduced 0.02%	4,999 $560,000
Q4 2021 Feb 09, 2022	SELL	$95.88 - $117.08 $26,367 - $32,197	-275 Reduced 5.21%	5,000 $560,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $24,228 - $30,599	-287 Reduced 5.16%	5,275 $506,000
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $9,946 - $12,459	-147 Reduced 2.57%	5,562 $466,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $38,023 - $42,989	567 Added 11.03%	5,709 $391,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $2,875 - $3,321	-45 Reduced 0.87%	5,142 $359,000
Q2 2020 Nov 12, 2020	BUY	$58.54 - $67.94 $10,946 - $12,704	187 Added 3.74%	5,187 $339,000
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $31,084 - $36,076	-531 Reduced 9.6%	5,000 $327,000
Q1 2020 May 07, 2020	BUY	$49.46 - $64.78 $8,160 - $10,688	165 Added 3.07%	5,531 $337,000
Q4 2019 Feb 12, 2020	SELL	$49.86 - $58.26 $35,749 - $41,772	-717 Reduced 11.79%	5,366 $311,000
Q3 2019 Nov 06, 2019	SELL	$47.54 - $53.43 $36,605 - $41,141	-770 Reduced 11.24%	6,083 $315,000
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $18,809 - $21,092	402 Added 6.23%	6,853 $350,000
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $32,775 - $37,280	789 Added 13.94%	6,451 $298,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $7,396 - $8,420	167 Added 3.04%	5,662 $262,000
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $266,452 - $319,479	5,495 New	5,495 $271,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.

Account

Tiedemann Advisors, LLC Novo Nordisk A S Transaction History